Fundz

Watching GoodRx Holdings, Inc.? See every signal: funding, hires, M&A, contracts, sentiment.

Book a demoChoose your plan
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →
Back to SEC Filings
Executive ChangeItem 5.02 · 8-KMEDIUM RiskNeutral

GoodRx Holdings, Inc.

www.goodrx.com
Filed: Jul 31, 2026CIK: 0001809519Software
Full company profileView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

GoodRx Holdings announced that Chief Financial Officer & Treasurer Christopher McGinnis will transition from his role effective August 5, 2026. The departure is not due to disagreements regarding operations or financial practices, but represents a significant change in financial leadership that could impact investor confidence and strategic direction.

Key Takeaways

Christopher McGinnis is departing as CFO & Treasurer effective August 5, 2026 at 11:59 p.m. ET

The company explicitly stated the departure is not due to any disagreements regarding operations or financial reporting

2 more takeaways

Filing Overview

Form Type8-K
Filing DateJul 31, 2026
Item5.02
CategoryExecutive Change
CIK0001809519
Accession #gdrx-20260731
Risk LevelMEDIUM
SentimentNeutral
Signalinformational
Topics
leadership transitionexecutive departure

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings

GoodRx Holdings, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.